Compounds modulating the hedgehog protein signaling pathway, marked forms thereof, and applications
US8981149B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Sep 21, 2012 |
| Grant date | Mar 17, 2015 |
| Priority date | — |
| Expiry date | Sep 21, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/57492
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to compounds of formula (I), and the use thereof as a drug, particularly for the treatment of tumors associated with hyperactivation of the hedgehog protein signaling pathway, treatment of neurodegenerative diseases, treatment of diseases related to cerebral development (holoprosencephaly), for stem cell monitoring treatment of cerebrovascular accidents and cardiovascular accidents, treatment of diseases involving oligodendrocytes and diseases involving neurolemmocytes, for application thereof in vitro for modulating human or animal stem cell renewal, and for the treatment of diabetes. The invention also relates to pharmaceutical compositions having a compound of formula (I). The invention also relates to a method for radio-marking compounds having formula (I), the marked compounds, and the use of the compounds as research tools, and method for screening and/or identifying ligands in the Smoothened receptor (Smo) binding sites, methods for identifying agonists and antagonists of the Smoothened receptor, and a method for identifying cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.